The various studies have shown that the level of APRIL in the serum of CLL patients are significantly higher than in normal individuals (Hahne et al., 1998a; Tecchio et al., 2011). The gene discussed is TNFSF13; the disease is B-cell chronic lymphocytic leukemia.